Lipid Nanoparticles (LNP) Market Research Report – Segmentation By Type (Nano-Structured Lipid Carriers (NLCs), Solid Lipid Nanoparticles (SLNs)); Application (Research, Therapeutics, Dental Implants, Wound Care, Tissue Regeneration, and Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-14967
Format:
Region: Global
Chapter 1. LIPID NANOPARTICLES (LNP) MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. LIPID NANOPARTICLES (LNP) MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. LIPID NANOPARTICLES (LNP) MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. LIPID NANOPARTICLES (LNP) MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. LIPID NANOPARTICLES (LNP) MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. LIPID NANOPARTICLES (LNP) MARKET – By Type
6.1. Nano-Structured Lipid Carriers (NLCs)
6.2. Solid Lipid Nanoparticles (SLNs)
Chapter 7. LIPID NANOPARTICLES (LNP) MARKET – By Application
7.1. Research
7.2. Therapeutics
Chapter 8. LIPID NANOPARTICLES (LNP) MARKET – By Region
8.1. North America
8.2. Europe
8.3.The Asia Pacific
8.4.Latin America
8.5. Middle-East and Africa
Chapter 9. LIPID NANOPARTICLES (LNP) MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. Merck KGaA
9.2. Evonik Industries AG
9.3. Gattefosse
9.4. Precision Nano System
9.5. IOI Oleo GMBH
9.5. Corden Pharma
9.6. Genevant Sciences
9.7. Alnylam
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Lipid Nanoparticles (LNP) Market was esteemed at USD 777.4 Million in 2022 and is projected to be a value of USD 2156.11 Million by 2030, growing at a fast CAGR of 13.6% during the forecast period 2023-2030.
The Global Lipid Nanoparticles (LNP) Market drives the Increasing Demand for RNA-based Therapeutics.
The Segments under the Global Lipid Nanoparticles (LNP) Market by the application are Research, Therapeutics.
USA and Canada are the most dominating countries in the North American region for the Global Lipid Nanoparticles (LNP) Market
Evonik Industries AG, Merck KGaA, and Precision Nano-System are the three major leading players in the Global Lipid Nanoparticles (LNP) Market.
